ClinicalTrials.Veeva

Menu

Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Breast Neoplasms
Colorectal Neoplasms
Ovarian Cancer
Stomach Neoplasms
Pancreatic Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT00419627
ProtHYMC

Details and patient eligibility

About

The purpose of this study is to evaluate the presence of proteins in solid tumors which may lead to an immune response

Full description

The main objective of the study is to evaluate which proteins are presented by the HLA complex of solid tumors. Secondary objectives include to evaluate whether an immune response specific to these proteins has actually been provoked and whether there is a similar immune response following recurrence. Real specimens will be evaluated using PCR and mass spectrometry.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with adenocarcinoma of breast, colon, rectum, ovary , stomach, pancreas

Exclusion criteria

  • Withdrawal of consent
  • Small specimen which does not allow to retrieve tissue without interfering with pathologic evaluation

Trial contacts and locations

1

Loading...

Central trial contact

Itamar Ashkenazi, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems